Company Profile

A biopharmaceutical company, Tambo, Inc. is structured around development and commercialization of drug delivery platforms, particularly those based on Click Activated Protodrugs (CAP). Principals of the firm are developing site-specific drug activation technologies to enhance efficacy and minimize toxicity. Projects to date have included development of new proto-drugs for tissue-targeted efficacy, and improving drug solubility and tolerability. Firm's leadership team are working on development of new ways to deliver drugs to specific locations in the body, allowing for targeted drug action and reduced side effects. Proto-drugs: in Use is a platform -- CAP -- to develop proto-drugs, i.e. inactive molecules that are activated at target site, ensuring that drug works only where it's needed. The firm's research to date has included developing proto-drugs for various disease indications, demonstrating favorable solubility in formulations, tolerability in mice, and effective action in tumor models. Patents: firm has patents related to processes for preparing functioialized cyclooctenes, which are part of the firm's drug delivery technology.